12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase.
Protein kinase C (PKC) activation is often antiapoptotic, although in a few cell types PKC initiates apoptosis by an unknown mechanism. Recent investigations showed that activation of PKC alpha by 12-O-tetradecanoylphorbol 13-acetate (TPA) induced apoptosis in LNCaP prostate cancer cells. The present studies examine the mechanism of this effect and show that de novo ceramide generation through the enzyme ceramide synthase is required. TPA induced rapid ceramide generation, which was detectable by 1 h and increased linearly for 12 h. TPA-induced apoptosis was measurable by 12 h and was progressive for 48 h. Investigations into the mechanism of TPA-induced ceramide generation revealed that acid and neutral sphingomyelinase activities were not enhanced. However, TPA induced an increase in ceramide synthase activity that persisted for at least 16 h. Treatment with fumonisin B1, a specific natural inhibitor of ceramide synthase, abrogated both ceramide production and TPA-induced apoptosis. Ceramide analogues bypassed fumonisin B1 inhibition to initiate apoptosis directly. Thus, ceramide appears to be a necessary signal for TPA-induced apoptosis in LNCaP cells. This represents the first description of a pathway by which PKC may signal apoptosis.
Garzotto
M
M
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
White-Jones
M
M
Jiang
Y
Y
Ehleiter
D
D
Liao
W C
WC
Haimovitz-Friedman
A
A
Fuks
Z
Z
Kolesnick
R
R
D000581:Amidohydrolases / Q000187:drug effects / Q000378:metabolism*; D017209:Apoptosis / Q000187:drug effects*; D002264:Carboxylic Acids / Q000494:pharmacology; D002273:Carcinogens / Q000494:pharmacology*; D002274:Carcinogens, Environmental / Q000494:pharmacology; D055572:Ceramidases; D002518:Ceramides / Q000096:biosynthesis*; D004347:Drug Interactions; D037341:Fumonisins; D006801:Humans; D008297:Male; D011493:Protein Kinase C / Q000187:drug effects* / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D002264:Carboxylic Acids; D002273:Carcinogens; D002274:Carcinogens, Environmental; D002518:Ceramides; D037341:Fumonisins; C056933:fumonisin B1; D011493:Protein Kinase C; D000581:Amidohydrolases; D055572:Ceramidases; D013755:Tetradecanoylphorbol Acetate